We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BIO Targets FDA Funding, User Fees in Next Congress
BIO Targets FDA Funding, User Fees in Next Congress
November 10, 2006
The biotechnology industry is focusing its lobbying efforts in the 110th Congress on ensuring that the FDA has sufficient appropriations and user fees to perform timely reviews of new products, an industry official says.